Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

October 23, 2020

Sirnaomics seals $105m Series D financing for RNAi therapeutics

Sirnaomics Inc., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that it has sealed its USD$105 million Series D financing.

Sirnaomics seals $105m Series D financing for RNAi therapeutics